Skip to Content

FDA panel backs Pfizer’s low-dose COVID-19 vaccine for kids

By LAURAN NEERGAARD and MATTHEW PERRONE
Associated Press

WASHINGTON (AP) — U.S. health advisers have endorsed kid-size doses of Pfizer’s COVID-19 vaccine for young children. The vote Tuesday by the Food and Drug Administration panel moves the nation closer to vaccinating children ages 5 to 11. The FDA isn’t bound by the recommendation and is expected to make its own decision within days. If regulators agree, shots could begin as early as late next week. Young kids would get just a third of the dose given to teens and adults. A study found kid-size vaccinations are nearly 91% effective at preventing symptomatic infections.

Article Topic Follows: Coronavirus

Jump to comments ↓

The Associated Press

Author Profile Photo

Adonis Albright

Adonis Albright anchors the News 11 shows at 5 PM, 6 PM, and 10 PM.

If you have a great story idea, you can reach him at adonis.albright@kecytv.com.

BE PART OF THE CONVERSATION

KYMA KECY is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content